The mammalian genome contains thousands of loci that transcribe long
noncoding RNAs (lncRNAs)1-3, some of which are known to play
critical roles in diverse cellular processes4-7. LncRNA loci can
contribute to cellular regulation through a variety of mechanisms: while some
encode RNAs that act non-locally (in trans)6,8,
emerging evidence indicates that many lncRNA loci act locally (in
cis)—for example, through functions of the lncRNA
promoter, the process of lncRNA transcription, or the lncRNA transcript itself
in regulating the expression of nearby genes7,9-11. Despite their potentially important
roles, it remains challenging to identify functional lncRNA loci and distinguish
among these and other mechanisms. To address these challenges, we developed a
genome-scale CRISPR-Cas9 activation screen targeting more than 10,000 lncRNA
transcriptional start sites to identify noncoding loci that influence a
phenotype of interest. We found 11 novel lncRNA loci that, upon recruitment of
an activator, each mediate BRAF inhibitor resistance in melanoma. We
investigated potential local and non-local mechanisms at these candidate loci
and found that most appear to regulate nearby genes. Detailed analysis of one
candidate, termed EMICERI, revealed that its transcriptional
activation results in dosage-dependent activation of four neighboring
protein-coding genes, one of which confers the resistance phenotype. Our
screening and characterization approach provides a CRISPR toolkit to
systematically discover functions of noncoding loci and elucidate their diverse
roles in gene regulation and cellular function.